SABS ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/6/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)-0.28
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)--
SAB Biotherapeutics Inc ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ SAB Biotherapeutics Inc ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ SAB Biotherapeutics Inc ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ SAB Biotherapeutics Inc ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ SAB Biotherapeutics Inc ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
SABS ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง--
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
SABS FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)0.22105.99%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)0.00-100.00%
SAB Biotherapeutics Inc(SABS) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/6/2026 | 06/2026 | -0.28/-0.29 | --/0.00 | 2.55% | -- |
| 5/12/2026 | 03/2026 | -0.35/-0.23 | --/0.00 | -54.29% | -- |
| 3/9/2026 | 12/2025 | -0.06/-0.20 | 0.00/0.00 | 70.17% | -- |
| 11/14/2025 | 09/2025 | 0.50/-0.51 | 0.00/100.00K | 198.95% | -100.00% |
| 8/7/2025 | 06/2025 | -1.09/-0.80 | 0.00/125.00K | -36.71% | -100.00% |
| 5/9/2025 | 03/2025 | -0.56/-1.03 | 0.00/333.33K | 45.70% | -100.00% |
| 3/31/2025 | 12/2024 | -1.23/-1.16 | 114.70K/120.00K | -5.36% | -4.42% |
| 11/6/2024 | 09/2024 | -1.12/-1.09 | 0.00/150.00K | -2.54% | -100.00% |